Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.63 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 8/20 | 0.54 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.52 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.48 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.46 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19266379 | 0.91 | CYP4F2 (0.77) | CYP4F2CYP4A11FFAR1FFAR4CYP4Z1 | |
| SCHEMBL21171688 | 0.90 | CYP4F2 (0.60) | CYP4F2CYP4A11FFAR1FFAR4CYP4Z1 | |
| SCHEMBL3091164 | 0.89 | FFAR1 (0.68) | CYP4F2CYP4A11FFAR1FFAR4NR1H4 | |
| SCHEMBL4889211 | 0.88 | CYP4F2 (0.80) | CYP4F2CYP4A11CYP4Z1LMNAL3MBTL1 | |
| SCHEMBL2773462 | 0.87 | FFAR1 (0.68) | CYP4F2CYP4A11FFAR1FFAR4NR1H4 | |
| SCHEMBL23074519 | 0.86 | CYP4F2 (0.56) | CYP4F2CYP4A11FFAR1FFAR4CYP4Z1 | |
| SCHEMBL21172120 | 0.85 | CYP4F2 (0.55) | CYP4F2CYP4A11FFAR1FFAR4CYP4Z1 | |
| SCHEMBL19266624 | 0.84 | CYP4F2 (0.54) | CYP4F2CYP4A11FFAR1FFAR4CYP4Z1 | |
| SCHEMBL12401878 | 0.83 | CYP4F2 (0.68) | CYP4F2CYP4A11CYP4Z1LMNAL3MBTL1 | |
| SCHEMBL23074514 | 0.83 | CYP4F2 (0.52) | CYP4F2CYP4A11FFAR1FFAR4CYP4Z1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2987791-B1 | 3-(4-(BENZYLOXY)PHENYL)HEX-4-INOIC ACID DERIVATIVE, SUITABLE FOR PREVENTING AND TREATING METABOLIC DISEASES | HYUNDAI PHARM CO LTD (KR) | 2019-07-17 | — | — | EP | disclosed |